Physician profile
Matthew E Bennett
NPI 1043579600
$22,901.54
in general payments reported to CMS, 2019-2025
12 companies · $1,417 in 2025
The $1,417 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $105 · 2022: $8.53 · 2024: $706 · 2025: $1,417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102 · Travel and Lodging: $1,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.16 |
| Travel and Lodging | $1,021.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $19,840.65 | 2019 | |
| W. L. Gore & Associates, INC. | $1,644.98 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis |
| Cook Medical LLC | $566.15 | 2019-2024 | Zenith Spiral-Z |
| Medtronic Vascular, INC. | $218.31 | 2019-2020 | |
| Shockwave Medical, INC | $215.77 | 2024-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave M5+ |
| Silk Road Medical, INC. | $158.79 | 2019 | |
| Kci USA, INC. | $117.64 | 2019 | |
| Biom'Up France Sas | $74.15 | 2020 | |
| Janssen Pharmaceuticals, INC | $26.67 | 2019 | |
| Inari Medical, INC. | $20.45 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Venclose INC. | $9.45 | 2020 | |
| Cardiovascular Systems INC. | $8.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.